A Phase III, Multicenter, Double-Blind, Placebo-controlled Study of the Safety and Efficacy of Intravenous Antegren (Natalizumab) in Subjects with Moderately to Severly Active Crohn's Disease with Elevated C-Reactive Protein

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/15/04 → 9/30/07